Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

National Health Research Institutes, Taiwan · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
phase ii, open-label, parallel 2-arm, multi-center, metastatic pancreatic cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 839038
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.